Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.

Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.

Item
http://www.wikidata.org/entity/Q37256662
Preclinical In vivo Imaging for Fat Tissue Identification, Quantification, and Functional CharacterizationClassification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and ObesityBrain and Brown Adipose Tissue Metabolism in Transgenic Tg2576 Mice Models of Alzheimer Disease Assessed Using 18F-FDG PET Imaging.Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice.Enhancement of 18F-fluorodeoxyglucose metabolism in rat brain frontal cortex using a β3 adrenoceptor agonistAtomoxetine prevents dexamethasone-induced skeletal muscle atrophy in miceInsights into Brown Adipose Tissue Physiology as Revealed by Imaging StudiesEffects of dietary phosphate on glucose and lipid metabolism.Preliminary evaluation of β3-adrenoceptor agonist-induced 18F-FDG metabolic activity of brown adipose tissue in obese Zucker rat.Evaluation of [11C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT.
P2860

Targeting presynaptic norepinephrine transporter in brown adipose tissue: a novel imaging approach and potential treatment for diabetes and obesity.

Item
http://www.wikidata.org/entity/Q37256662
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Targeting presynaptic norepine ...... ment for diabetes and obesity.
@en
Targeting presynaptic norepine ...... ment for diabetes and obesity.
@nl
type
label
Targeting presynaptic norepine ...... ment for diabetes and obesity.
@en
Targeting presynaptic norepine ...... ment for diabetes and obesity.
@nl
prefLabel
Targeting presynaptic norepine ...... ment for diabetes and obesity.
@en
Targeting presynaptic norepine ...... ment for diabetes and obesity.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Targeting presynaptic norepine ...... tment for diabetes and obesity
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932